alnylam
The Regional Business Director will lead and manage a high‑performing team of Business Account Executives to drive disease awareness and product education for AMVUTTRA® (vutrisiran) among healthcare professionals treating hATTR amyloidosis. The role focuses on coaching, strategic planning, market insight, and resource allocation to meet and exceed performance targets while fostering a customer‑oriented culture.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2002
Alnylam is a biopharmaceutical company that has pioneered RNA interference (RNAi) therapeutics, an innovative class of medicines that treats diseases by silencing the genes that cause or contribute to them. The company develops RNAi-based medicines targeting both rare and prevalent diseases across multiple therapeutic areas, with approved products and a robust investigational pipeline. Driven by science and inspired by patients, Alnylam is committed to delivering transformational medicines that address diseases at their genetic source.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for alnylam.
37% above the average for this role
South Region Rsd Regional Sales Director Us Nf1 Pn South Wilmington Delaware United States Of America
AstraZeneca
Regional Rare Disease Lead
UCB
Therapeutic Account Manager
Mirum Pharmaceuticals
Therapeutic Account Manager
Mirum Pharmaceuticals
Therapeutic Account Manager
Mirum Pharmaceuticals
Therapeutic Account Manager
Mirum Pharmaceuticals